ISPC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

iSpecimen Insider Trading History Chart

iSpecimen Share Price & Price History

^$1.28

▲ +0.216 (20.38%)

As of 04/1/2025 03:31 PM ET

Days: 30 | 90 | 365

iSpecimen Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/14/2023	Benjamin Bielak	Insider	Buy	18,000	$0.72	$12,960.00	84,348
5/31/2023	Tracy Curley	CEO	Buy	4,400	$1.25	$5,500.00	49,541

SEC Filings (Institutional Ownership Changes) for iSpecimen (NASDAQ:ISPC)

13.62% of iSpecimen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

iSpecimen Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Bridgeway Capital Management LLC	21,800	$58K	0.0%	N/A	2.271%
7/22/2022	Grimes & Company Inc.	62,014	$0.14M	0.0%	+78.3%	0.699%
5/18/2022	Teton Advisors Inc.	40,000	$0.22M	0.0%	N/A	0.454%
5/11/2022	Bleichroeder LP	65,834	$0.67M	0.1%	-80.8%	0.747%
5/6/2022	Grimes & Company Inc.	34,771	$0.19M	0.0%	N/A	0.394%
2/15/2022	Kepos Capital LP	190,000	$1.48M	0.1%	-15.6%	2.177%
2/10/2022	Bleichroeder LP	342,180	$2.83M	0.4%	-44.6%	3.920%
2/8/2022	Main Street Financial Solutions LLC	10,500	$82K	0.0%	N/A	0.120%
11/16/2021	Bleichroeder LP	618,180	$3.61M	0.6%	+3.0%	8.835%
11/9/2021	BlackRock Inc.	6,007	$35K	0.0%	N/A	0.086%
10/27/2021	Telemus Capital LLC	24,400	$0.14M	0.0%	N/A	0.352%
8/17/2021	Bleichroeder LP	600,291	$4.33M	0.7%	N/A	8.671%
8/12/2021	Kepos Capital LP	225,000	$1.63M	0.1%	N/A	3.466%
8/11/2021	Susquehanna International Group LLP	11,842	$85K	0.0%	N/A	0.182%

Data available starting January 2016

See Full Table

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Today's Range

Now: $1.28

$1.02

$1.41

50 Day Range

MA: $1.71

$1.06

$2.41

52 Week Range

Now: $1.28

$1.03

$11.80

Volume

455,957 shs

Average Volume

411,131 shs

Market Capitalization

$1.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.65

Who are the company insiders with the largest holdings of iSpecimen?: iSpecimen's top insider shareholders include:
Benjamin Bielak (Insider)
Tracy Curley (CEO)
Learn More about top insider investors at iSpecimen.